Journal of Anesthesia

, Volume 33, Issue 2, pp 257–265 | Cite as

Amyotrophic lateral sclerosis and anesthesia: a case series and review of the literature

  • Alan M. Hoeper
  • David W. Barbara
  • James C. Watson
  • Juraj Sprung
  • Toby N. WeingartenEmail author
Original Article



Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that leads to death due to respiratory failure. This report describes the perioperative characteristics of ALS patients who underwent procedures with anesthesia at our institution.


We reviewed perioperative records of ALS patients who underwent procedures with anesthesia from January 1, 2014, through December 31, 2015.


Seventy-eight patients underwent 89 procedures (71 procedures with monitored anesthesia care and 18 with general anesthesia), including 45 gastrostomy tube placements and 18 bone marrow biopsies. Three patients had prolonged duration of postoperative intubation related to preexisting respiratory muscle weakness, and one patient with bilateral pneumothorax required tracheal reintubation for respiratory distress. Four patients had prolonged duration of hospitalization. Three patients were hospitalized for ALS-related complications, and one patient was hospitalized for respiratory distress when pneumoperitoneum developed after gastrostomy tube placement. Three of these patients died of complications attributable to ALS within 30 days of the procedure. Twenty-nine (32.6%) procedures required minimal sedation (e.g., bone marrow biopsy, cataract surgery) and were performed on an ambulatory basis.


When caring for patients with ALS, the perioperative team must be prepared to treat potentially complex medical conditions that may not be directly related to the procedure and anesthetic management. However, minor procedures performed with minimal sedation may be safely performed on an ambulatory basis.


Amyotrophic lateral sclerosis Anesthesia Outcomes 



Amyotrophic lateral sclerosis


Amyotrophic lateral sclerosis functional rating scale-revised




Monitored anesthesia care


Percutaneous endogastric gastrostomy


Compliance with ethical standards

Conflict of interest

TNW currently serves as a consultant to Medtronic in the role as chairman of the Clinical Endpoint Committee for the Prodigy Trial; has received research support from Respiratory Motion (study equipment) and unrestricted investigator-initiated grants from Merck (active) and Baxter (completed).

Supplementary material

540_2019_2611_MOESM1_ESM.doc (38 kb)
Supplementary material 1 (DOC 38 KB)


  1. 1.
    Creemers H, Grupstra H, Nollet F, van den Berg LH, Beelen A. Prognostic factors for the course of functional status of patients with ALS: a systematic review. J Neurol. 2015;262(6):1407–23.PubMedCrossRefGoogle Scholar
  2. 2.
    Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169(1–2):13–21.PubMedCrossRefGoogle Scholar
  3. 3.
    Tilanus TBM, Groothuis JT, TenBroek-Pastoor JMC, Feuth TB, Heijdra YF, Slenders JPL, et al. The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis. Respir Res. 2017;18(1):144.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Mateen FJ, Carone M, Sorenson EJ. Patients who survive 5 years or more with ALS in Olmsted county, 1925–2004. J Neurol Neurosurg Psychiatry. 2010;81(10):1144–6.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12(4):368–80.PubMedCrossRefGoogle Scholar
  6. 6.
    Al-Chalabi A, van den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol. 2017;13(2):96–104.PubMedCrossRefGoogle Scholar
  7. 7.
    Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, et al. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Ann Neurol. 2013;74(5):699–708.PubMedCrossRefGoogle Scholar
  8. 8.
    Marin B, Boumediene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46(1):57–74.PubMedGoogle Scholar
  9. 9.
    Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2012;14(3):CD001447.Google Scholar
  10. 10.
    Castrillo-Viguera C, Grasso DL, Simpson E, Shefner J, Cudkowicz ME. Clinical significance in the change of decline in ALSFRS-R. Amyotroph Lateral Scler. 2010;11(1–2):178–80.PubMedCrossRefGoogle Scholar
  11. 11.
    Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, et al. Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a clinical trials. JAMA Neurol. 2016;73(3):337–44.PubMedCrossRefGoogle Scholar
  12. 12.
    Prabhakar A, Owen CP, Kaye AD. Anesthetic management of the patient with amyotrophic lateral sclerosis. J Anesth. 2013;27(6):909–18.PubMedCrossRefGoogle Scholar
  13. 13.
    Kirstein MM, Korner S, Schneider A, Manns MP, Petri S, Voigtlander T. Percutaneous endoscopic gastrostomy with and without jejunal extension in patients with amyotrophic lateral sclerosis. Eur J Gastroenterol Hepatol. 2018;30(3):257–62.PubMedCrossRefGoogle Scholar
  14. 14.
    Thompson AG, Blackwell V, Marsden R, Millard E, Lawson C, Nickol AH, et al. A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3–4):243–8.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Strijbos D, Hofstede J, Keszthelyi D, Masclee AAM, Gilissen LPL. Percutaneous endoscopic gastrostomy under conscious sedation in patients with amyotrophic lateral sclerosis is safe: an observational study. Eur J Gastroenterol Hepatol. 2017;29(11):1303–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Sato Y, Goshi S, Kawauchi Y, Nishigaki Y, Mizuno KI, Hashimoto S, et al. Safety of unsedated PEG placement using transoral ultrathin endoscopy in patients with amyotrophic lateral sclerosis. Nutr Neurosci. 2017;20(1):71–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Liu S, Liu Z, Zhang J, Li Z, Hu Z, Yang W, et al. Anesthetic strategy for percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis patients. Int J Clin Exp Med. 2017;10(2):3725–30.Google Scholar
  18. 18.
    Kak M, Issa NP, Roos RP, Sweitzer BJ, Gottlieb O, Guralnick A, et al. Gastrostomy tube placement is safe in advanced amyotrophic lateral sclerosis. Neurol Res. 2017;39(1):16–22.Google Scholar
  19. 19.
    Monsma M, Osseyran F, Monzó Z, Silla I, Doménech R, Argente P. Soporte respiratorio durante procedimientos endoscópicos bajo sedación. Experiencia en 13 pacientes afectados de esclerosis lateral amiotrófica. Rev Argent Anestesiol. 2016;74(3):98–103. CrossRefGoogle Scholar
  20. 20.
    Kawa C, Stewart J, Hilden K, Adler DG, Tietze C, Bromberg MB, et al. A retrospective study of nurse-assisted propofol sedation in patients with amyotrophic lateral sclerosis undergoing percutaneous endoscopic gastrostomy. Nutr Clin Pract. 2012;27(4):540–4.PubMedCrossRefGoogle Scholar
  21. 21.
    You TM, Kim S. Pulseless electrical activity during general anesthesia induction in patients with amyotrophic lateral sclerosis. J Dent Anesth Pain Med. 2017;17(3):235–40.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Yoo JH, Kim SI, Park SY, Jun MR, Kim YE, Kim HJ. Use of sugammadex in a patient with progressive muscular atrophy and in a patient with amyotrophic lateral sclerosis: case report. Medicine (Baltimore). 2017;96(23):e7098.CrossRefGoogle Scholar
  23. 23.
    Xiao W, Zhao L, Wang F, Sun H, Wang T, Zhao G. Total intravenous anesthesia without muscle relaxant in a parturient with amyotrophic lateral sclerosis undergoing cesarean section: a case report. J Clin Anesth. 2017;36:107–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Thourot M, Cornillon B, Robert R, Royer D, Patrigeon RG. Hyperkaliémie menaçante suite à une injection de succinylcholine orientant le diagnostic vers une sclérose latérale amyotrophique. Anesth Reanim Anesth Reanim. 2017;3(2):193–7.***Google Scholar
  25. 25.
    Hayashi K, Araki R, Tanaka A. Electroencephalographic monitoring during sevoflurane anaesthesia in an amyotrophic lateral sclerosis patient with locked-in state. J Clin Neurosci. 2017;43:126–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Chang TB, Huh J. Delayed neuromuscular recovery after use of sugammadex in a patient with amyotrophic lateral sclerosis: a case report. Anaesth Pain Intensive Care Anaesth Pain Intensive Care. 2017;21(4):475–8.Google Scholar
  27. 27.
    Nafissi S, Kazemi H, Tiraihi T, Beladi-Moghadam N, Faghihzadeh S, Faghihzadeh E, et al. Intraspinal delivery of bone marrow stromal cell-derived neural stem cells in patients with amyotrophic lateral sclerosis: a safety and feasibility study. J Neurol Sci. 2016;362:174–81.PubMedCrossRefGoogle Scholar
  28. 28.
    Trivedi S, Tibrewala N, Balsara KP. Anaesthetic management of a patient with amyotrophic lateral sclerosis undergoing laparoscopic diaphragmatic pacing. Indian J Anaesth. 2015;59(10):683–5.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Olivieri C, Castioni CA, Livigni S, Bersano E, Cantello R, Della Corte F, et al. Non-invasive ventilation after surgery in amyotrophic lateral sclerosis. Acta Neurol Scand. 2014;129(4):e16–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Thampi SM, David D, Chandy TT, Nandhakumar A. Anesthetic management of a patient with amyotrophic lateral sclerosis for transurethral resection of bladder tumor. Indian J Anaesth. 2013;57(2):197–9.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Kelsaka E, Karakaya D, Zengin EC. Use of sugammadex in a patient with amyotrophic lateral sclerosis. Med Princ Pract. 2013;22(3):304–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Schmiesing CA, Lee J, Morton JM, Brock-Utne JG. Laparoscopic diaphragmatic pacer placement—a potential new treatment for ALS patients: a brief description of the device and anesthetic issues. J Clin Anesth. 2010;22(7):549–52.PubMedCrossRefGoogle Scholar
  33. 33.
    Onders RP, Carlin AM, Elmo M, Sivashankaran S, Katirji B, Schilz R. Amyotrophic lateral sclerosis: the Midwestern surgical experience with the diaphragm pacing stimulation system shows that general anesthesia can be safely performed. Am J Surg. 2009;197(3):386–90.PubMedCrossRefGoogle Scholar
  34. 34.
    Lee D, Lee KC, Kim JY, Park YS, Chang YJ. Total intravenous anesthesia without muscle relaxant in a patient with amyotrophic lateral sclerosis. J Anesth. 2008;22(4):443–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Kowalik MM, Smiatacz T, Pajuro R, Skowronski R, Trocha H, Nyka W, et al. Anaesthesia for ophthalmologic surgical procedures in a patient with advanced amyotrophic lateral sclerosis: a case report. Cases J. 2008;1(1):338.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Hadaya IA, Gray AT, Braehler MR. Baclofen pump replacement in a patient with end-stage amyotrophic lateral sclerosis: a case report demonstrating transversus abdominis plane block as the sole anesthetic. A A Pract. 2018;10(10):251–3.PubMedCrossRefGoogle Scholar
  37. 37.
    Ciftci B, Ekinci M, Karakaya MA, Uzunoglu E, Kose EA. Anesthesia management for ALS and WPW. J Clin Anal Med. 2018;9(4):353–5.CrossRefGoogle Scholar
  38. 38.
    Moreno-Gonzales R, Vásquez-Rojas G, Rojas Fun M. Anestesia para cesárea en paciente con esclerosis lateral amiotrófica: reporte de caso. Rev Colomb Anestesiol. 2017;45:86–9.CrossRefGoogle Scholar
  39. 39.
    Gu J, Lin X. Anesthesia and postoperative analgesia for a patient with amyotrophic lateral sclerosis. Miner Anestesiol. 2017;83(11):1216–7.Google Scholar
  40. 40.
    Kalava A, Clendenen S, McKinney JM, Bojaxhi E, Greengrass RA. Bilateral thoracic paravertebral nerve blocks for placement of percutaneous radiologic gastrostomy in patients with amyotrophic lateral sclerosis: a case series. Rom J Anaesth Intensive Care. 2016;23(2):149–53.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Agnoletti V, Corso R, Cattano D, Novi A, Piraccini E, Folli S, et al. Thoracic paravertebral block for breast surgery in a patient with amyotrophic lateral sclerosis. Miner Anestesiol. 2013;79(7):822–3.Google Scholar
  42. 42.
    Sertoz N, Karaman S. Peripheral nerve block in a patient with amyotrophic lateral sclerosis. J Anesth. 2012;26(2):314–5.PubMedCrossRefGoogle Scholar
  43. 43.
    Park KB, Son B, Hwang DY, Jeon Y. Spinal anesthetic management for discectomy in a patient with amyotrophic lateral sclerosis—a case report. Korean J Anesthesiol. 2012;63(6):547–9.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Hobaika AB, Neves BS. Combined spinal-epidural block in a patient with amyotrophic lateral sclerosis: case report. Rev Bras Anestesiol. 2009;59(2):206–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Chang YJ, Jung WS, Son WR, Jo YY. Discordance between train-of-four response and clinical symptoms in a patient with amyotrophic lateral sclerosis. Acta Med Okayama. 2014;68(2):125–7.PubMedGoogle Scholar

Copyright information

© Japanese Society of Anesthesiologists 2019

Authors and Affiliations

  1. 1.Department of Anesthesiology and Perioperative MedicineMayo ClinicRochesterUSA
  2. 2.Department of NeurologyMayo ClinicRochesterUSA

Personalised recommendations